bibliographic entry 5819202 [be/5819202]
https://w3id.org/oc/corpus/be/5819202

is a
content
  • Liaw, YF, Xie, Q, Han, KH, Gane, EJ, Piratvusuth, T, McCloud, PI. Shorter duration and lower dose of peginterferon alpha-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180ug: Neptune study [Abstract], Hepatology, 2011, 52, Suppl 1, 112A
references